Cipher Pharmaceuticals Q1 EPS $0.10 Down From $0.20 YoY, Sales $12.02M Miss $17.14M Estimate

Benzinga · 05/08 21:02
Cipher Pharmaceuticals (TSX:CPH) reported quarterly earnings of $0.10 per share. This is a 50 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $12.02 million which missed the analyst consensus estimate of $17.14 million by 29.88 percent. This is a 104.86 percent increase over sales of $5.87 million the same period last year.